The results of western blot assay and dot-blots assay demonstrated that, compared to that in LR-MSCs from the mouse in sham group, both the levels of METTL3 expression and m6A modification were increased in LR-MSCs from the bleomycin-induced fibrosis model (Fig. 3G, H). The gene discussed is METTL3; the disease is fibrosis.